Business
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow
TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, will announce its fourth quarter and full year 2025 financial results after market close on Thursday, March 5, 2026. Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. F
About this update from Profound Medical Corp
[{"type":"image","alt":"Profound Medical Corp.","displaySize":"","headline":null,"caption":"Profound Medical Corp.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":39,"url":"https://media.zenfs.com/en/globenewswire.com/706e95b61981393723638191940b98c5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/oleh9hsLn64FmkZjOMsmoQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTU1O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/706e95b61981393723638191940b98c5","width":300,"height":39}},"lazy":false},{"type":"text","content":"TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, will announce its fourth quarter and full year 2025 financial results after market close on Thursday, March 5, 2026.","length":353,"tagName":"p"},{"type":"text","content":"Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period.","length":144,"tagName":"p"},{"type":"text","content":"Fourth Quarter and Full Year 2025 Results Conference Call Details:","length":66,"tagName":"p"},{"type":"text","content":"Date: Thursday, March 5, 2026","length":29,"tagName":"p"},{"type":"text","content":"Time: 4:30 p.m. ET","length":18,"tagName":"p"},{"type":"text","content":"Live Call Registration: https://register-conf.media-server.com/register/BI9b6f3d29fd3749db83543442274147c2","length":106,"tagName":"p"},{"type":"text","content":"The call will also be broadcast live and archived on the Company's website in the Investors section here.","length":109,"tagName":"p"},{"type":"text","content":"About Profound Medical Corp.","length":28,"tagName":"p"},{"type":"text","content":"Profound is a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures.","length":128,"tagName":"p"},{"type":"text","content":"Profound is commercializing TULSA-PRO®, a technology that combines real-time MRI, AI-enhanced planning, robotically-driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA Procedure™, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate di...